Cerus (CERS) EPS (Basic) (QoQ) (2010 - 2026)
Cerus (CERS) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.92% |
| Dec 31, 2025 | -10,890.82% |
| Sep 30, 2025 | 99.65% |
| Jun 30, 2025 | 27.59% |
| Mar 31, 2025 | -262.95% |
| Dec 31, 2024 | 28.16% |
| Sep 30, 2024 | 49.32% |
| Jun 30, 2024 | 41.33% |
| Mar 31, 2024 | -592.65% |
| Dec 31, 2023 | 80.92% |
| Sep 30, 2023 | 45.44% |
| Jun 30, 2023 | 15.87% |
| Mar 31, 2023 | -7.68% |
| Dec 31, 2022 | -69.47% |
| Sep 30, 2022 | -1.33% |
| Jun 30, 2022 | 32.61% |
| Mar 31, 2022 | -572.89% |
| Dec 31, 2021 | 120.58% |
| Sep 30, 2021 | 19.35% |
| Jun 30, 2021 | 13.25% |